An evaluation of bioequivalence of two 7-day 17β-estradiol transdermal delivery systems by anatomical site

Journal of Clinical Pharmacology

Volumn 42, Issue 10, 2002, Pages 1134-1141

  Harrison, Lester I ^a   Harari, David ^b  

^a 3M COMPANY   (United States)

^b Hillcrest Obstetrics/Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; ESTRONE SULFATE;

ABDOMEN; ADHESION; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BUTTOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; ERYTHEMA; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HUMAN; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SKIN EDEMA; SKIN IRRITATION; SKIN MANIFESTATION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; AGED; AREA UNDER CURVE; BUTTOCKS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTRONE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; THERAPEUTIC EQUIVALENCY;

EID: 0036786384     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127002401382740     Document Type: Article

References (17)

1. Lobo RA, Ettinger B, Hutchinson KA, Knopp RH, Lindsay R, Nachtigall LE, et al: Estrogen replacement: the evolving role of transdermal delivery. J Reprod Med 1996;41(Suppl. 10):781-796.
2. Andersson TLG, Stehle B, Davidsson B, Höglund P: Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest® and Climara®. Maturitas 2000;34:57-64.
3. Gordon SF: Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Am J Obstet Gynecol 1995;173:998-1004.
4. Notelovitz M: Clinical experience with a 7-day estrogen patch: principles and practice. Gynecol Endocrinol 1998;12:249-258.
5. Berti JJ, Lipsky JJ: Transcutaneous drug delivery: a practical review. Mayo Clin Proc 1995;70(6):581-586.
6. Wester RC, Maibach HJ: Percutaneous absorption of drugs. Clin Pharmacokinet 1992;23(4):253-266.
7. Boyd RA, Yang B-B, Abel RB, Eldon MA, Sedman AJ, Forgue ST: Pharmacokinetics of a 7-day 17β-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estrone. J Clin Pharmacol 1996;36: 998-1005.
8. Taggart W, Dandekar K, Ellman H, Notelovitz M: The effect of site of application on the transcutaneous absorption of 17-β estradiol from a transdermal delivery system (Climara). Menopause 2000;7(5): 364-369.
9. Mylan Technologies, Inc. ANDA 75-233, summary basis of approval, 2000.
10. Mylan Pharmaceuticals, Inc. Estradiol Transdermal System (once-a-week formulation), continuous delivery for once-weekly application. Prescribing information, May 1999.
11. Patel HI, Tsai KT: Analysis of paired ordered categorical data in a factorial design. J Biopharm Stat 1996;6(1):15-36.
12. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. Rockville, MD: U.S. Department of Health and Human Services, 2000.
13. NOP World, Edison (NJ). Omnitel estrogen supplements study, August 2001.
14. Utian WH, Burry KA, Archer DF, Gallagher JC, Boyett RL, Guy MP, et al: Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study Group. Am J Obstet Gynecol 1999;181:71-79.
15. McKeever C, McIlwain H, Greenwald M, Gupta N, Jayawardene S, Huels G, Roberts M: An estradiol matrix transdermal system for the prevention of postmenopausal loss. Clin Ther 2000;22:845-857.
16. Good WR, John VA, Ramirez M, Higgins JE: Double-masked, multicenter study of an estradiol matrix transdermal delivery (Alora) versus placebo in postmenopausal women experiencing menopausal symptoms. Alora Study Group. Clin Ther 1996;18:1093-1105.
17. Harrison LI, Riedel DJ, Chang SF, Jacobson JP, Sellers JA, Kannianen CM, et al: Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patch. Therap Drug Monit 1997;19:37-42.